history of glp 1 Glucagon-like peptide-1 receptor: mechanisms and advances in therapy History of GLP 1 Agonists

Initially, GLP-1 medication was developed to treat type 2 diabetes and, although it is effective, other significant weight loss benefits were also found , leading to their use as a weight management tool

It demonstrated to have a safety profile similar to GLP-1RA not increasing the risk of hypoglycemia ( In the SURPASS-2 study, TZP at the dose of 5, 10, and 15 mg were compared to the GLP-1RA semaglutide (1 mg once weekly) in patients not well controlled in therapy only with metformin (71)

Semaglutide vs Tirzepatide: How the Mechanisms Differ The cleanest way to frame the Semaglutide vs Tirzepatide mechanism contrast is single versus dual incretin engagement

Toxicity has been demonstrated by extremely high oral doses, but this is uncommon